Comparing Enhanced Cognitive-behavior Therapy and Family-based Treatment for Adolescents With an Eating Disorder

NCT06256380 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-12-24

No results posted yet for this study

Summary

The goal of this randomized controlled clinical trial is to compare the efficacy of outpatient family-based treatment versus enhanced cognitive behavior therapy for children and adolescents with eating disorders.

Because of insufficient recruitment, the study design was modified on December 1st, 2025, to a partially randomized preference design.

The main aim is to determine if enhanced cognitive behavior therapy has a similar efficacy as family-based treatment among children and adolescents with eating disorders receiving treatment in an outpatient setting. The main outcome is improvement in eating disorders psychopathology at the end of treatment.

Conditions

  • Feeding and Eating Disorders

Interventions

BEHAVIORAL

Enhanced Cognitive-behavior therapy for adolescents with an eating disorder

Psychotherapy

BEHAVIORAL

Family-based therapy for adolescents with an eating disorder

Psychotherapy

Sponsors & Collaborators

  • South-Eastern Norway Regional Health Authority

    collaborator OTHER
  • University of Oslo

    collaborator OTHER
  • Villa Garda Hospital

    collaborator OTHER
  • University of California, San Francisco

    collaborator OTHER
  • St. Olavs Hospital

    collaborator OTHER
  • University Hospital of North Norway

    collaborator OTHER
  • Haukeland University Hospital

    collaborator OTHER
  • Vestre Viken Hospital Trust

    collaborator OTHER
  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Øyvind Rø, MD · Oslo University Hospital

  • Ingrid Funderud, PhD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-07
Primary Completion
2028-12-31
Completion
2033-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06256380 on ClinicalTrials.gov